News

A recent cohort study of 20 emergency departments assessed allergic contact dermatitis cases.

Catherine Nester, RN, and Dr. Stephen Kingsmore, discuss the pivotal role of newborn screening in diagnosing rare diseases along with the impact that BeginNGS can have on the future of rare disease medicine.

In total, 64.9% of patients who achieved clinical response with ustekinumab during induction were in symptomatic remission after 44 weeks.

Sotatercept added to background therapy demonstrated significant improvement in exercise capacity compared to placebo.

New data indicate a statistically not significant increase in the rate of treatment for PH, but investigators stress its potential clinical importance.

A retrospective analysis of controlled drug dispensation shows conflicting rates of prescriptions to teenagers and young adults.

Treatment initiation was lower among Medicaid and private health insurance recipients aged 18-29 years, compared with patients aged 50-59 years.

The approval indicates the subcutaneous loop diuretic for the at-home treatment of congestion in adults with NYHA Class II/III chronic heart failure.

The risk of primary composite cardiovascular outcomes was reduced by 47%, while the risk of secondary cardiovascular disease outcomes was reduced by 50% in patients with bariatric surgery compared to nonsurgical patients.

Children at risk for developing asthma may see benefits from a new screening tool developed to detect symptoms in children age 3 and up.

More than 80 000 pterygium excisions in the IRIS Registry suggest young, male, and publicly insured patients had an elevated risk of reoperation within 5 years.

Both drug classes would improve type 2 diabetes outcomes as first-line agents, but costs would be need to be reduced by at least 70% to be considered cost-effective.

A research team described data regarding the potential of escalating adalimumab doses for certain patients with psoriasis.

In Philadelphia, 28% of the patient population was unscreened, with the factors associated with lower risks of being unscreened generally associated with a higher HCV positivity rate.

The approval, awarded to Alnylam Pharmaceuticals, is based on the results of the ILLUMINATE-C phase 3 trial.

Greater psychological resilience was associated with lower BMI, fewer hospitalizations, and greater mental QOL in the T2D population.

The results also show a bigger increase among adults between 2012-2017, which could be due to increased sensitivity of diagnosis.

The observed reductions in CV mortality in patients treated with dapagliflozin were primarily due to lower rates of HF and sudden death.

A recent study found that worsened visual acuity and depression were associated with neurobiological changes visible through MRI scans.

A new analysis suggests raise levels of zinc, iron, lead and aluminum—linked to cigarette use—is positively correlated with insomnia.

Recent qualitative studies found social isolation in patients with IBD is 1 of the main obstacles to leading a normal life.

A duration-response analysis of 1-mg dosage produced a 5% decrease in suicidal events per month of additional treatment.

A combination therapy approach may be useful for psoriasis treatment, though an 8-week regimen may not be long enough.

The new recommendations call for posterior partial fundoplication over total posterior or anterior 90° fundoplication in adult patients with GERD and anterior >90° fundoplication as an alternative.

Martha Gulati, MD, joins The Heart Team to share her professional experiences and recommendations in treating female-specific cardiovascular disease.

Overall, 30.60% of pediatric patients who presented to the emergency department with mild head trauma were diagnosed with ADHD, compared to 8.96% of the control group.

Martha Gulati, MD, joins episode 2 to discuss the burden of gender disparity in cardiovascular research, screening and care.